Business Description
Handa Pharmaceuticals Inc
ISIN : TW0006620008
Total Employee Number:
13Description
Handa Pharmaceuticals Inc is a Taiwan-based specialty pharmaceutical company. It is engaged in the development of niche drugs. The company focuses on the development of high-barrier/patentable niche products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 81.93 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 300.55 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 14.44 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 92 | |||||
3-Year Book Growth Rate | 83.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.28 | |||||
9-Day RSI | 36.61 | |||||
14-Day RSI | 40.1 | |||||
3-1 Month Momentum % | 23.57 | |||||
6-1 Month Momentum % | 15.33 | |||||
12-1 Month Momentum % | 7.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.91 | |||||
Quick Ratio | 8.91 | |||||
Cash Ratio | 7.82 | |||||
Days Inventory | 56.46 | |||||
Days Sales Outstanding | 106.77 | |||||
Days Payable | 36.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.68 | |||||
Dividend Payout Ratio | 0.3 | |||||
Forward Dividend Yield % | 2.68 | |||||
5-Year Yield-on-Cost % | 2.68 | |||||
3-Year Average Share Buyback Ratio | -8.4 | |||||
Shareholder Yield % | -3.29 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.83 | |||||
Operating Margin % | 54.18 | |||||
Net Margin % | 44.41 | |||||
EBITDA Margin % | 65.03 | |||||
FCF Margin % | 18.39 | |||||
OCF Margin % | 20.4 | |||||
ROE % | 15.88 | |||||
ROA % | 14.76 | |||||
ROIC % | 42.24 | |||||
3-Year ROIIC % | 49.11 | |||||
ROC (Joel Greenblatt) % | 269.45 | |||||
ROCE % | 19.51 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.53 | |||||
Forward PE Ratio | 16.82 | |||||
PE Ratio without NRI | 15.53 | |||||
Shiller PE Ratio | 94.96 | |||||
Price-to-Owner-Earnings | 36.29 | |||||
PS Ratio | 7.01 | |||||
PB Ratio | 2.43 | |||||
Price-to-Tangible-Book | 2.83 | |||||
Price-to-Free-Cash-Flow | 39.59 | |||||
Price-to-Operating-Cash-Flow | 35.68 | |||||
EV-to-EBIT | 9.01 | |||||
EV-to-EBITDA | 7.72 | |||||
EV-to-Revenue | 5.02 | |||||
EV-to-FCF | 27.39 | |||||
Price-to-GF-Value | 0.5 | |||||
Price-to-Projected-FCF | 1.96 | |||||
Price-to-Graham-Number | 1.4 | |||||
| Price-to-Net-Current-Asset-Value | 3.48 | |||||
| Price-to-Net-Cash | 4.05 | |||||
Earnings Yield (Greenblatt) % | 11.1 | |||||
FCF Yield % | 2.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Handa Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,758.057 | ||
| EPS (TTM) (NT$) | 4.97 | ||
| Beta | 0.3013 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.28 | ||
| Volatility % | 75.18 | ||
| 14-Day RSI | 40.1 | ||
| 14-Day ATR (NT$) | 4.861298 | ||
| 20-Day SMA (NT$) | 84.535 | ||
| 12-1 Month Momentum % | 7.32 | ||
| 52-Week Range (NT$) | 64.1 - 154 | ||
| Shares Outstanding (Mil) | 162.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Handa Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Handa Pharmaceuticals Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 2.073848 Cash Dividend | 2026-07-06 | 102.50 (+2.50%) | ||
| TWD 1.506791 Cash Dividend | 2025-07-02 | 84.10 (+0.36%) |
Show
Entries
Handa Pharmaceuticals Inc Frequently Asked Questions
What is Handa Pharmaceuticals Inc(ROCO:6620)'s stock price today?
The current price of ROCO:6620 is NT$77.20. The 52 week high of ROCO:6620 is NT$154.00 and 52 week low is NT$64.10.
When is next earnings date of Handa Pharmaceuticals Inc(ROCO:6620)?
The next earnings date of Handa Pharmaceuticals Inc(ROCO:6620) is .
Does Handa Pharmaceuticals Inc(ROCO:6620) pay dividends? If so, how much?
The Dividend Yield %  of Handa Pharmaceuticals Inc(ROCO:6620) is 2.68% (As of Today), Highest Dividend Payout Ratio of Handa Pharmaceuticals Inc(ROCO:6620) was 0.31. The lowest was 0.3. And the median was 0.31. The  Forward Dividend Yield % of Handa Pharmaceuticals Inc(ROCO:6620) is 2.68%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Handa Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers